A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy

FASEB Journal

Volumn 15, Issue 13, 2001, Pages 2508-2514

  Purves, Tertia ^a   Middlemas, Alicia ^a   Agthong, Sithiporn ^a   Jude, Edward B ^a   Boulton, Andrew J M ^a   Fernyhough, Paul ^a   Tomlinson, David R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Diabetes; DRG; MAPK; Stress

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; SPINAL GANGLION; STREPTOZOCIN DIABETES; SURAL NERVE;

ANIMALS; BUTADIENES; CELL SURVIVAL; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; GANGLIA, SPINAL; GLUCOSE; HUMANS; HYDROGEN PEROXIDE; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS, AFFERENT; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RATS; RATS, WISTAR; SURAL NERVE;

EID: 0035158585     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0253hyp     Document Type: Article

References (45)

1. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population
2. Diabetic peripheral neuropathies: Their cost to patient and society and the value of knowledge of risk factors for development of interventions
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
4. Diabetic neuropathies
5. Diabetic neuropathies: Features and mechanisms
6. Pathologic alterations in the diabetic neuropathies of humans: A review
7. The aldose reductase pathway and nonenzymatic glycation in the pathogenesis of diabetic neuropathy: A critical review for the end of the 20th century
8. The therapeutic potential of neurotrophins for the treatment of diabetic neuropathy
9. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat
10. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats
11. Effect of a-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve
12. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats, comparison with essential fatty acids
13. Mitogen-activated protein kinases as glucose transducers for diabetic complications
14. Mitogen-activated protein kinase cascades and the signaling of hyperosmotic stress to immediate early genes
15. Evolution of osmotic stress signaling via map kinase cascades
16. The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell survival
17. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs
18. The mitogen-activated protein kinases system (MAP kinase cascade): Its role in skin signal transduction. A review
19. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions
20. Mechanisms of mitogen-activated protein kinase activation in experimental diabetes
21. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways
22. ras -dependent mitogen-activated protein kinase pathway regulated by oxidant stress
23. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1
24. The phosphorylation state of MAP-kinases modulates the cytotoxic response of smooth muscle cells to hydrogen peroxide
25. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases
26. Differential activation of ERK, JNK/ SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite
27. 2-terminal kinase-1 (JNK1) activation by ultravioet-B radiation and by oxidative stressors
28. Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants
29. The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell surviral
30. Peripheral target regulation of the development and survival of spinal sensory and motor neurons in the chick embryo
31. A simple colorimetric method for determination of protein
32. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
33. Enhancement of expression of stress proteins by agents that lower the levels of glutathione in cells
34. Mechanism of protection by zinc against mercuric chloride toxicity in rats: Effects of zinc and mercury on glutathionine metabolism
35. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy
36. Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress
37. The c-Jun transcription factor - Bipotential mediator of neuronal death, survival and regeneration
38. Aberrant stress-induced phosphorylation of perikaryal neurofilaments
39. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M
40. Dystrophic axonal swellings develop as a function of age and diabetes in human dorsal root ganglia
41. Reduced perikaryal volume of lower motor and primary sensory neurons in early experimental diabetes
42. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
43. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats
44. Peripheral axotomy induces long-term c-Jun amino-terminal-kinase-1 activation and activator protein-1 binding activity by c-Jun and jun D in adult rat dorsal root ganglia in vivo
45. 2-terminal kinases after neuronal injury